Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IOVA – Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.
IOVA
$2.68
Name : Iovance Biotherapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $894,943,168.00
EPSttm : -1.22
finviz dynamic chart for IOVA
Iovance Biotherapeutics, Inc.
$2.68
4.28%
$0.11

Float Short %

36.33

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.11

EPS Last/This Y

0.2

EPS This/Next Y

0.39

Price

2.68

Target Price

10

Analyst Recom

2.08

Performance Q

-19.52

Relative Volume

0.9

Beta

0.88

Ticker: IOVA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04IOVA1.750.130.18150916
2025-07-07IOVA1.6950.130.01148182
2025-07-08IOVA1.770.120.05151244
2025-07-09IOVA1.980.120.07151398
2025-07-10IOVA1.920.120.03157016
2025-07-11IOVA1.870.120.11157759
2025-07-14IOVA1.9950.120.04157020
2025-07-15IOVA1.9350.120.18161828
2025-07-16IOVA2.230.120.10164637
2025-07-17IOVA2.350.120.06169539
2025-07-18IOVA2.230.120.23174697
2025-07-21IOVA2.490.120.28171389
2025-07-22IOVA3.150.130.08175150
2025-07-23IOVA3.970.140.16189299
2025-07-24IOVA3.290.150.22217006
2025-07-25IOVA3.120.170.40222603
2025-07-28IOVA2.950.170.28200931
2025-07-29IOVA2.920.170.17204145
2025-07-30IOVA2.670.170.45205377
2025-07-31IOVA2.570.170.41209902
2025-08-01IOVA2.680.170.22210990
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04IOVA1.7520.8-15.1-1.06
2025-07-07IOVA1.6920.814.6-1.06
2025-07-08IOVA1.7720.8-51.6-1.06
2025-07-09IOVA1.9920.8-122.0-1.06
2025-07-10IOVA1.9320.88.3-1.06
2025-07-11IOVA1.8720.831.3-1.06
2025-07-14IOVA2.0120.8-75.5-1.06
2025-07-15IOVA1.9420.811.3-1.06
2025-07-16IOVA2.2420.8-137.3-1.06
2025-07-17IOVA2.3420.8-49.1-1.06
2025-07-18IOVA2.2420.814.3-1.06
2025-07-21IOVA2.5020.8-99.3-1.06
2025-07-22IOVA3.1420.8-186.4-1.06
2025-07-23IOVA3.9720.8-171.3-1.06
2025-07-24IOVA3.2918.777.6-1.06
2025-07-25IOVA3.1318.713.4-1.08
2025-07-28IOVA2.9118.725.5-1.08
2025-07-29IOVA2.9218.7-8.7-1.08
2025-07-30IOVA2.6718.736.8-1.08
2025-07-31IOVA2.5718.79.0-1.08
2025-08-01IOVA2.6818.7-42.3-1.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04IOVA0.10-0.6433.51
2025-07-07IOVA0.10-0.7833.51
2025-07-08IOVA0.10-0.7833.51
2025-07-09IOVA0.10-0.7833.51
2025-07-10IOVA0.10-0.7833.51
2025-07-11IOVA0.10-0.7835.65
2025-07-14IOVA0.10-0.4635.65
2025-07-15IOVA0.10-0.4635.66
2025-07-16IOVA0.10-0.4635.66
2025-07-17IOVA0.10-0.4635.66
2025-07-18IOVA0.10-0.4635.66
2025-07-21IOVA0.100.2935.66
2025-07-22IOVA0.100.2935.66
2025-07-23IOVA0.100.2935.66
2025-07-24IOVA0.100.2935.66
2025-07-25IOVA0.100.2936.34
2025-07-28IOVA0.10-1.5236.34
2025-07-29IOVA0.10-1.5236.34
2025-07-30IOVA0.10-1.5236.34
2025-07-31IOVA0.10-1.5236.34
2025-08-01IOVA0.10-1.5236.33
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

0.1

Institutional Transactions

-1.52

Beta

0.88

Average Sales Estimate Current Quarter

67

Average Sales Estimate Next Quarter

78

Fair Value

Quality Score

25

Growth Score

29

Sentiment Score

29

Actual DrawDown %

95.1

Max Drawdown 5-Year %

-96.8

Target Price

10

P/E

Forward P/E

PEG

P/S

4.21

P/B

1.17

P/Free Cash Flow

EPS

-1.23

Average EPS Est. Cur. Y​

-1.08

EPS Next Y. (Est.)

-0.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-176.49

Relative Volume

0.9

Return on Equity vs Sector %

-72.6

Return on Equity vs Industry %

-54

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-42.3
Iovance Biotherapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 838
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
stock quote shares IOVA – Iovance Biotherapeutics, Inc. Stock Price stock today
news today IOVA – Iovance Biotherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IOVA – Iovance Biotherapeutics, Inc. yahoo finance google finance
stock history IOVA – Iovance Biotherapeutics, Inc. invest stock market
stock prices IOVA premarket after hours
ticker IOVA fair value insiders trading